The short version of certificate of analysis fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-08-30. Anything still debated is marked as such rather than presented as settled.
TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H68N10O14 | Acetylated heptapeptide form |
| Monoisotopic mass | 888.5 Da | Average mass about 889 Da |
| Appearance | White to off-white solid | Usually supplied as lyophilised powder |
| Solubility class | Highly water soluble | Also dissolves in aqueous buffers |
| Common synonyms | Tbeta4 fragment, thymosin beta-4 (17-23) | Refer to the same sequence |
Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
Identity and purity are checked with chromatographic and mass spectrometric methods. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities, while mass spectrometry confirms the expected molecular mass. A certificate of analysis may report a purity percentage, but the laboratory should still verify the material independently. Common quality concerns include truncated sequences, deamidation, oxidation, and residual solvents from synthesis. Because TB-500 is short, some impurities can differ from the target by only a few mass units.
Reconstitution practices affect downstream measurements. The dry powder is typically dissolved in sterile water or a suitable aqueous buffer, then mixed gently rather than vortexed at high speed. Visible particles or cloudiness suggest incomplete dissolution or contamination and should be investigated. For long-term storage, aliquots should be labeled with concentration, solvent, and date. Open questions include how different buffers alter peptide conformation and whether specific container materials adsorb the peptide. Those variables can change apparent concentration in assays even when the chemical identity is correct.
Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.
Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.
Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.
An example of an RNA aptamer therapy includes Pegaptanib (aka Macugen ® ), the only FDA-approved RNA aptamer treatment. Originally approved in 2004 to treat age-related macular degeneration, Pegaptanib is a 28 nucleotide RNA aptamer that acts as a VEGF antagonist. However, it is not as effective as antibody-based treatments such as bevacizumab and ranibizumab. Another example of an RNA aptamer therapeutic is NOX-A12, a 45 nucleotide RNA aptamer that is in clinical trials for chronic lymphocytic leukemia, pancreatic cancer, as well as other cancers. NOX-A12 acts as antagonist for CXCL12/SDF-1, a chemokine involved in tumor growth.
=== Pure element applications === Molybdenum powder is used as a fertilizer for some plants, such as cauliflower. Elemental molybdenum is used in NO, NO2, NOx analyzers in power plants for pollution controls. At 350 °C (662 °F), the element acts as a catalyst for NO2/NOx to form NO molecules for detection by infrared light. Molybdenum anodes replace tungsten in certain low voltage X-ray sources for specialized uses such as mammography. The radioactive isotope molybdenum-99 is used to generate technetium-99m, a short-lived daughter radionuclide (t½ ≃ 6.0 h) needed for medical imaging. The radioisotope is handled and stored as the molybdate (MoO2−4).
Tho told Kissinger that the Khmer Rouge's leader, Pol Pot, was a Vietnamphobe and that North Vietnam had very limited influence over him. At the same time, Kissinger reported to Nixon that "only a miracle" could save South Vietnam now, as Thiệu showed no signs of making the necessary reforms to allow the ARVN to fight. His assessment of Cambodia was even bleaker, as the Lon Nol regime had lost control of much of the countryside by the spring of 1973, and only American air strikes prevented the Khmer Rouge from taking Phnom Penh. Between March–May 1973, American bombers dropped 95,000 tons of bombs on Cambodia, while American fighters dropped another 15,000 tons of bombs. On 4 June 1973, the Senate passed a bill that already cleared the House of Representatives to block funding for any American military operations in Indochina, and Kissinger spent much of the summer of 1973 lobbying Congress to extend the deadline to 15 August in order to keep bombing Cambodia. The Lon Nol regime was saved in 1973 due to heavy American bombing, but the cutoff in funding ended the possibility of an American return to Southeast Asia. The PAVN had taken heavy losses in the Easter Offensive, but the North Vietnamese were rebuilding their strength for a new offensive. By the spring of 1973, Nixon was caught up in the Watergate scandal and was losing interest in foreign affairs. Kissinger was angry that the Secretary of State, William Rogers, had not resigned so he take could over the State Department, shouting: "And now's he's hanging on just as I said he would. Piece by piece. Bit by bit.
Sources: en.wikipedia.org
Belize became the first country in the world to completely ban bottom trawling in December 2010. In December 2015, Belize banned offshore oil drilling within 1 km (0.6 mi) of the Barrier Reef and all of its seven World Heritage Sites. In 2017, the Government and people of Belize made marine conservation history implementing an indefinite moratorium on offshore oil activities everywhere Belize exercises maritime jurisdiction. This move was further bolstered when the Government enacted law which requires a referendum if there is any move to lift the moratorium. Despite these protective measures, the reef remains under threat from oceanic pollution as well as uncontrolled tourism, shipping, and fishing. Other threats include hurricanes, climate change and the resulting increase in ocean temperatures, which causes coral bleaching. It is claimed by scientists that over 40% of Belize's coral reef has been damaged since 1998.
Most people with back pain do not experience chronic severe pain but rather persistent or intermittent pain that is mild or moderate. Still, chronic back pain symptoms, defined as repeated or persistent pain for at least 3 months within the past 12 months, affected 34.4% of a nationwide sample of adults in mild form, 25.1% in moderate form, and 13% in (very) severe form. In most cases of herniated disks and stenosis, rest, injections or surgery have similar general pain-resolution outcomes on average after one year. In the United States, acute low back pain is the fifth most common reason for physician visits and causes 40% of missed work days. It is the single leading cause of disability worldwide. According to the World Health Organization, approximately 90% of all low back pain cases are non-specific, meaning that no clear structural cause can be identified.
The core −C(=O)−(N) of amides is called the amide group (specifically, carboxamide group). In the usual nomenclature, one adds the term "amide" to the stem of the parent acid's name. For instance, the amide derived from acetic acid is named acetamide (CH3CONH2). IUPAC recommends ethanamide, but this and related formal names are rarely encountered. When the amide is derived from a primary or secondary amine, the substituents on nitrogen are indicated first in the name. Thus, the amide formed from dimethylamine and acetic acid is N,N-dimethylacetamide (CH3CONMe2, where Me = CH3). Usually even this name is simplified to dimethylacetamide. Cyclic amides are called lactams; they are necessarily secondary or tertiary amides.
Sources: en.wikipedia.org
== Guest characters == Fragrantian Erika (フラグラント星人 衛里香, Furanguranto Seijin Erika): The princess of a royal intergalactic family from Planet Fragrant. She is kidnapped by Kevakia, who attempts to ransom her for the rare-but-powerful Wellness Stone, but she is rescued by Ban and Hoji, who delete Kevakia. Erika is portrayed by Risa Yoshiki (吉木 りさ, Yoshiki Risa). Doltockian Mano Mark (ドルトック星人マノ・マーク, Dorutokku Seijin Mano Māku): A scientist from Planet Doltock who attempts to deal with Beildon under the alias of Iwaki (岩木), only to be arrested for abetting the Alienizer's crimes. His human form is portrayed by Minosuke (みのすけ). Juuzaian Braidy (ジューザ星人ブライディ, Jūza Seijin Buraidi): A mantis-themed alien from Planet Juuza whom Kersus framed for the murder of her sister Karmia and Agent Abrella enlarged to distract the Dekarangers, who discover the truth and arrest Braidy for causing property damage in his enlarged state. Braidy is voiced by Yūsuke Numata (沼田 祐介, Numata Yūsuke). Hikaru Hiwatari (日渡 氷狩, Hiwatari Hikaru): A young ESPer with the ability to teleport inanimate objects. Originally a street wanderer, he hated humans because they mistreated him due to his powers, and he wanted to leave the planet as soon as possible. An Alienizer named Dazgonelr uses this to manipulate Hikaru into helping him commit crimes, until Jasmine convinces Hikaru to trust her. Following Dazgonelr's deletion, Hikaru leaves Earth to join S.P.D.'s training academy.
The Pizarro passed the deserted island of Cubagua, once prosperous due to its pearl fisheries, and neared the mountainous coast of Margarita. Humboldt spent his last night at sea conversing with del Pino about the region’s exotic wildlife and plants, forming a valuable friendship. At dawn on July 16, Humboldt and Bonpland saw the lush South American mainland for the first time. The Pizarro anchored at Cumana after a voyage of forty-one days from La Coruña, marking the end of their Atlantic crossing and the beginning of their explorations in the New World.
Numerous protesters asked for a civilian government. On Saturday 13 April 2019, al-Burhan announced that a civilian government would soon be established. Al-Burhan promised that the transitional period would take a maximum of two years. Negotiations started to take place with the opposition leaders to achieve this.
Sources: en.wikipedia.org
No. TB-500 is a short synthetic peptide matching residues 17 to 23 of thymosin beta-4, while the parent protein contains 43 residues. The fragment lacks the rest of the protein sequence, so the two are related but not identical.
It consists of leucine, lysine, lysine, threonine, glutamic acid, threonine, and glutamine in that order. The N-terminal leucine is usually acetylated in the forms described in catalogues.
Controlled human data is limited, and most published findings come from cell culture or animal work. This makes it difficult to state clinical effects with confidence.
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.